Co-expression of MDR-associated Markers, Including P-170, MRP and LRP and Cytoskeletal Proteins, in Three Resistant Variants of the Human Ovarian Carcinoma Cell Line, OAW42

Author： Moran E.   Cleary I.   Larkin A.M.   Amhlaoibh R.N.   Masterson A.   Scheper R.J.   Izquierdo M.A.   Center M.   O'Sullivan F.   Clynes M.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.4, 1997-04, pp. : 652-660

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma

By Schwarzenbach Heidi  

Medical Oncology, Vol. 19, Iss. 2, 2002-06 ,pp. : 87-104

Humana Press, Inc

Access to resources Recommend Favorite

Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression

By Chen Hongmin   Wang Li   Beretov Julia   Hao Jingli   Xiao Weiwei   Li Yong  

Clinical and Experimental Metastasis, Vol. 27, Iss. 8, 2010-12 ,pp. : 557-569

Springer Publishing Company

Access to resources Recommend Favorite

Rapid Recovery of a Functional MDR Phenotype Caused by MRP After a Transient Exposure to MDR Drugs in a Revertant Human Lung Cancer Cell Line

By Manzano R.G.   Versanvoort C.   Wright K.   Twentyman P.R.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2136-2141

Elsevier

Access to resources Recommend Favorite

Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade

By Komdeur R.   Plaat B.E.C.   van der Graaf W.T.A.   Hoekstra H.J.   Hollema H.   van den Berg E.   Zwart N.   Scheper R.J.   Molenaar W.M.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 909-916

Elsevier

Access to resources Recommend Favorite

The Influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts

By Boven E.   Jansen W.J.M.   Hulscher T.M.   Beijnen J.H.   van Tellingen O.  

European Journal of Cancer, Vol. 35, Iss. 5, 1999-05 ,pp. : 840-849

Elsevier

Access to resources Recommend Favorite